Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FESS plus mometasone furoate–soaked Nasopore for chronic rhinosinusitis with nasal polyps
ChiCTR2500104616Phase 4Not yet recruiting
- Sponsor
- Yongchuan Hospital Affiliated to Chongqing Medical University
- Start
- Jun 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of mometasone in chronic rhinosinusitis with nasal polyps (CRSwNP) (3 arms), sponsored by Yongchuan Hospital Affiliated to Chongqing Medical University. Primary endpoints: Sino-Nasal Outcome Test-22 (SNOT-22), Sinus CT Lund-Mackay score and 6 more. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
mometasone
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on ChiCTR2500104616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500104616.